Image

Phase 1/2 Study of REGN5458 in Adult Patients With Relapsed or Refractory Multiple Myeloma

Study testing REGN5458 for relapsed or refractory multiple myeloma.

Recruiting
18 years and older
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)
Study Summary

This study is to learn about how safe a new medicine called REGN5458 is and to find the right dose for patients with Multiple Myeloma. Multiple Myeloma is a type of cancer that affects certain blood cells. The study also aims to see if REGN5458 can help treat cancer.

Things being studied:

  • Possible side effects of REGN5458
  • How REGN5458 acts inside the body
  • The amount of REGN5458 in the blood
  • How REGN5458 might help in treating cancer

Eligibility: Adults with Multiple Myeloma, especially those who have tried at least 3 different treatments without success, can join. They must not have certain conditions like plasma cell leukemia or recent stem cell transplants.

Key Points:

  • The study has several parts and will take time to complete.
  • Participants will receive REGN5458 and will be monitored for side effects.
  • Compensation and specific risks are discussed with participants before joining.
Print
Study details
    Multiple Myeloma

NCT03761108

Regeneron Pharmaceuticals

8 March 2025

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.